Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

El, Khoury, R; Brodmann, M; Schneider, PA.
Progress on developing an effective below-the-knee drug-coated balloon.
REV CARDIOVASC MED. 2021; 22(3): 585-595. Doi: 10.31083/j.rcm2203070 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Brodmann Marianne

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Infrapopliteal atherosclerotic disease continues to present the greatest conundrum for effective endovascular therapies. To date, conventional angioplasty has been fraught with early restenosis and recoil in these complex, long, calcified, and occlusive lesions. The success of metallic drug-eluting stents in coronary arteries has not carried over to below-the-knee arteries. Initial promise in paclitaxel-coated balloons has not been demonstrated in large randomized clinical trials. Furthermore, the potential association between paclitaxel and mortality continues to generate tremendous controversy. The goal of this review article is to discuss the evolution and challenges of drug-coated balloon (DCB) science, present the clinical results of currently available tibial DCBs, and introduce new horizons in DCB technology.

Find related publications in this database (using NLM MeSH Indexing)

Angioplasty, Balloon - adverse effects

Cardiovascular Agents - adverse effects

Coated Materials, Biocompatible - administration & dosage

Humans - administration & dosage

Peripheral Arterial Disease - diagnostic imaging, therapy

Pharmaceutical Preparations - administration & dosage

Popliteal Artery - administration & dosage

Treatment Outcome - administration & dosage

Vascular Patency - administration & dosage

Find related publications in this database (Keywords)

Drug-coated balloon

Device design

Below-the-knee

Infrapopliteal

Peripheral arterial disease

© Med Uni Graz • Imprint